Medicines advice

Search Filters

Know what you're looking for?

Submission type

British National Formulary - Chapter

Pharmaceutical company

From

To

Advice

Accepted Not recommended Restricted Superseded Withdrawn Interim acceptance

Process

End of life/orphan Ultra orphan

Additional Details

Patient Access Scheme

Advanced Search

SMC ID	Date	Medicine	Submission Type	Indication
SMC2910	13/07/2026	tebentafusp (Kimmtrak)	Resubmission	For treatment of HLA-A*02:01-positive adult patients with advanced (unresectable or metastatic) uveal melanoma.

No medicines have been found.